BACKGROUND: We examined in this randomized, double-blind study whether a multilevel paravertebral block performed before general anesthesia with propofol and a laryngeal mask enhances postoperative analgesiaafter breast cancer surgery. METHODS:Eighty-eight patients were randomized to receive paravertebral injections with either ropivacaine 0.5% (30 mL) or an equivalent amount of isotonic saline. Nine patients were excluded after randomization, thus 79 patients remained for evaluation (ropivacaine, n = 38; placebo, n = 41). Variables of efficacy were the amount of fentanyl delivered by the patient-controlled analgesia device in the postanesthesia care unit (PACU), postoperative pain measured on a numeric rating scale at regular intervals from the day of surgery and until the second postoperative day. RESULTS: The median consumption of fentanyl in the PACU was less in the ropivacaine group compared with the placebo group (0 microg [range: 0-250 microg] versus 100 microg [range: 0-800 microg], P = 0.001). Also, fewer patients in the ropivacaine group reported pain > or =3 on the numbers rating scale in the PACU (13 vs 31, P < 0.0001). No statistical difference in pain scores or consumption of analgesics could be demonstrated after discharge from the PACU. CONCLUSIONS: A multilevel paravertebral block provides good analgesia for breast surgery, but the duration of analgesia is briefer than described in previous studies.
RCT Entities:
BACKGROUND: We examined in this randomized, double-blind study whether a multilevel paravertebral block performed before general anesthesia with propofol and a laryngeal mask enhances postoperative analgesia after breast cancer surgery. METHODS: Eighty-eight patients were randomized to receive paravertebral injections with either ropivacaine 0.5% (30 mL) or an equivalent amount of isotonic saline. Nine patients were excluded after randomization, thus 79 patients remained for evaluation (ropivacaine, n = 38; placebo, n = 41). Variables of efficacy were the amount of fentanyl delivered by the patient-controlled analgesia device in the postanesthesia care unit (PACU), postoperative pain measured on a numeric rating scale at regular intervals from the day of surgery and until the second postoperative day. RESULTS: The median consumption of fentanyl in the PACU was less in the ropivacaine group compared with the placebo group (0 microg [range: 0-250 microg] versus 100 microg [range: 0-800 microg], P = 0.001). Also, fewer patients in the ropivacaine group reported pain > or =3 on the numbers rating scale in the PACU (13 vs 31, P < 0.0001). No statistical difference in pain scores or consumption of analgesics could be demonstrated after discharge from the PACU. CONCLUSIONS: A multilevel paravertebral block provides good analgesia for breast surgery, but the duration of analgesia is briefer than described in previous studies.
Authors: Brian M Ilfeld; Sarah J Madison; Preetham J Suresh; Navparkash S Sandhu; Nicholas J Kormylo; Nisha Malhotra; Vanessa J Loland; Mark S Wallace; James A Proudfoot; Anya C Morgan; Cindy H Wen; Anne M Wallace Journal: Reg Anesth Pain Med Date: 2014 Mar-Apr Impact factor: 6.288
Authors: Jon D Klingensmith; Asher L Haggard; Jack T Ralston; Beidi Qiang; Russell J Fedewa; Hesham Elsharkawy; David Geoffrey Vince Journal: J Med Imaging (Bellingham) Date: 2019-11-07
Authors: F J Vogelaar; R Abegg; J C van der Linden; H G J M Cornelisse; F R C van Dorsten; V E Lemmens; K Bosscha Journal: Int J Colorectal Dis Date: 2015-04-28 Impact factor: 2.571
Authors: Judy C Boughey; Farzin Goravanchi; Ronald N Parris; Spencer S Kee; Alicia M Kowalski; John C Frenzel; Isabelle Bedrosian; Funda Meric-Bernstam; Kelly K Hunt; Frederick C Ames; Henry M Kuerer; Anthony Lucci Journal: Am J Surg Date: 2009-05-09 Impact factor: 2.565
Authors: Alan David Kaye; Nayan Patel; Franklin Rivera Bueno; Brad Hymel; Nalini Vadivelu; Gopal Kodumudi; Richard D Urman Journal: Ochsner J Date: 2014
Authors: Michelle C Janelsins; Karen M Mustian; Luke J Peppone; Lisa K Sprod; Michelle Shayne; Supriya Mohile; Kavita Chandwani; Jennifer S Gewandter; Gary R Morrow Journal: J Cancer Sci Ther Date: 2011-09-29